Ali Salahpour
Ali Salahpour
Associate Professor, Department of Pharamcology and Toxicology, University of Toronto
Verified email at
Cited by
Cited by
Detection of β2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET)
S Angers, A Salahpour, E Joly, S Hilairet, D Chelsky, M Dennis, M Bouvier
Proceedings of the National Academy of Sciences 97 (7), 3684-3689, 2000
DIMERIZATION: An Emerging Concept for G Protein–Coupled Receptor Ontogeny and Function
S Angers, A Salahpour, M Bouvier
Annual review of pharmacology and toxicology 42 (1), 409-435, 2002
Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants
JP Morello, A Salahpour, A Laperrière, V Bernier, MF Arthus, M Lonergan, ...
The Journal of clinical investigation 105 (7), 887-895, 2000
Quantitative assessment of β1-and β2-adrenergic receptor homo-and heterodimerization by bioluminescence resonance energy transfer
JF Mercier, A Salahpour, S Angers, A Breit, M Bouvier
Journal of Biological Chemistry 277 (47), 44925-44931, 2002
Homodimerization of the β2-adrenergic receptor as a prerequisite for cell surface targeting
A Salahpour, S Angers, JF Mercier, M Lagacé, S Marullo, M Bouvier
Journal of Biological Chemistry 279 (32), 33390-33397, 2004
Antagonism of dopamine D2 receptor/β-arrestin 2 interaction is a common property of clinically effective antipsychotics
B Masri, A Salahpour, M Didriksen, V Ghisi, JM Beaulieu, RR Gainetdinov, ...
Proceedings of the National Academy of Sciences 105 (36), 13656-13661, 2008
Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo
JM Beaulieu, E Tirotta, TD Sotnikova, B Masri, A Salahpour, ...
Journal of Neuroscience 27 (4), 881-885, 2007
β1/β2-adrenergic receptor heterodimerization regulates β2-adrenergic receptor internalization and ERK signaling efficacy
C Lavoie, JF Mercier, A Salahpour, D Umapathy, A Breit, LR Villeneuve, ...
Journal of Biological Chemistry 277 (38), 35402-35410, 2002
Pharmacologic chaperones as a potential treatment for X-linked nephrogenic diabetes insipidus
V Bernier, JP Morello, A Zarruk, N Debrand, A Salahpour, M Lonergan, ...
Journal of the American Society of Nephrology 17 (1), 232-243, 2006
Increased amphetamine-induced hyperactivity and reward in mice overexpressing the dopamine transporter
A Salahpour, AJ Ramsey, IO Medvedev, B Kile, TD Sotnikova, ...
Proceedings of the National Academy of Sciences 105 (11), 4405-4410, 2008
Increased vesicular monoamine transporter enhances dopamine release and opposes Parkinson disease-related neurodegeneration in vivo
KM Lohr, AI Bernstein, KA Stout, AR Dunn, CR Lazo, SP Alter, M Wang, ...
Proceedings of the National Academy of Sciences 111 (27), 9977-9982, 2014
Functional interaction between trace amine-associated receptor 1 and dopamine D2 receptor
S Espinoza, A Salahpour, B Masri, TD Sotnikova, M Messa, LS Barak, ...
Molecular pharmacology 80 (3), 416-425, 2011
Functional significance of oligomerization of G-protein-coupled receptors
A Salahpour, S Angers, M Bouvier
Trends in Endocrinology & Metabolism 11 (5), 163-168, 2000
Pharmacological characterization of membrane-expressed human trace amine-associated receptor 1 (TAAR1) by a bioluminescence resonance energy transfer cAMP biosensor
LS Barak, A Salahpour, X Zhang, B Masri, TD Sotnikova, AJ Ramsey, ...
Molecular pharmacology 74 (3), 585-594, 2008
Increased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and l-DOPA reversible motor deficits
ST Masoud, LM Vecchio, Y Bergeron, MM Hossain, LT Nguyen, ...
Neurobiology of disease 74, 66-75, 2015
Smoothened signal transduction is promoted by G protein-coupled receptor kinase 2
AR Meloni, GB Fralish, P Kelly, A Salahpour, JK Chen, RJ Wechsler-Reya, ...
Molecular and cellular biology 26 (20), 7550-7560, 2006
BRET biosensors to study GPCR biology, pharmacology, and signal transduction
A Salahpour, S Espinoza, B Masri, V Lam, LS Barak, RR Gainetdinov
Frontiers in endocrinology 3, 105, 2012
Association of calnexin with wild type and mutant AVPR2 that cause nephrogenic diabetes insipidus
JP Morello, A Salahpour, UE Petäjä-Repo, A Laperrière, M Lonergan, ...
Biochemistry 40 (23), 6766-6775, 2001
Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease
KM Lohr, ST Masoud, A Salahpour, GW Miller
European Journal of Neuroscience 45 (1), 20-33, 2017
The dopamine metabolite 3-methoxytyramine is a neuromodulator
TD Sotnikova, JM Beaulieu, S Espinoza, B Masri, X Zhang, A Salahpour, ...
PloS one 5 (10), e13452, 2010
The system can't perform the operation now. Try again later.
Articles 1–20